台湾使用血液样本进行AI-动力多癌症测试,以便更早发现。 Taiwan launches AI-powered multi-cancer test using blood samples for earlier detection.

2025年11月22日在台湾发射的AI驱动的多癌症早期检测试验SPOT-MAS, 利用无细胞DNA的多组分析来更早和更准确地识别癌症。 SPOT-MAS, an AI-driven multi-cancer early detection test, launched in Taiwan on November 22, 2025, using multi-omics analysis of cell-free DNA to identify cancer earlier and more accurately. 它由Gene Solutions with Gene Health开发,旨在将筛查范围扩大到政府方案涵盖的五个癌症类型以外,解决因无症状病例而晚期诊断的问题。 Developed by Gene Solutions with Gene Health, it aims to expand screening beyond the five cancer types covered by government programs, addressing late diagnoses due to asymptomatic cases. 反映台湾日益重视精密肿瘤学, 专家认为这可以提高存活率, Experts say it could improve survival rates by enabling earlier intervention and enhancing preventive care, reflecting Taiwan’s growing focus on precision oncology.